Excerpta Medica
|
This article is part of the Pharma_Portal project of Spinwatch. |
Excerpta Medica is a 'strategic medical communications agency'. It 'partners' with its clients in the pharmaceutical and biotech industry to 'educate the global health care community'.[1] It is owned by Elsevier, part of Reed Elsevier.
Contents
History
Activities
Publishing Fake Journals
The website notes that 'In an earlier version of this case study, we stated that a “company-sponsored journal” was created when in fact this was a “company-sponsored publication”.'[2]
As of August 2009 the company discloses its policy on Industry sponsorship:
- Content for Excerpta Medica’s Industry-Sponsored Publications is developed under the direction of an outside expert (eg, editor-in-chief, guest editor). Consistent with the Uniform Requirements and other generally accepted publication practices, Excerpta Medica distinguishes between authors and contributors. Authors are responsible for each article’s final content and are uniquely authorized to approve an article prior to its release/publication. Contributors are those individuals who helped to create the article, but who did not meet the criteria for authorship. Contributors are acknowledged in a manner that is appropriate for the publication (eg, on a Web site; on a masthead; in an acknowledgements section). Contributors may include, but are not limited to: copy editors; freelance writers; production staff; etc. The identity of the sponsor(s) for these publications is disclosed.[3]
The policy distinguishes between 'authors' and 'contributors' in a way that disguises the role of PR agencies and other ghost writers in process of publication.
List of Fake Journals
Australasian Journal of Bone & Joint Medicine, Australasian Journal of General Practice, the Australasian Journal of Neurology, the Australasian Journal of Cardiology, the Australasian Journal of Clinical Pharmacy, the Australasian Journal of Cardiovascular Medicine.[4]
List of current journals (2009)
- American Journal of Geriatric Pharmacotherapy | Clinical Therapeutics | Current Therapeutic Research | Gender Medicine[5]
People
Mark Flanick, Vice President, Marketing & Business Development (USA) m.flanick@elsevier.com | Edward Roos, Global Managing Director e.roos@elsevier.com | Kathleen Coughlan, Marketing Director, Excerpta Medica Interactive k.coughlan@elsevier.com
Management Team Members
| David Benson, Business Controller | Amanda Horsford, Managing Director, Excerpta Medica Interactive | Mark Flanick, Vice President, Marketing & Business Development (USA) | Suzanne Hayes, Vice President, Operations | Rosa Real MD, CMPP, Director, Global Medical Communications | Brian O'Connor, US Managing Director | Erika Qualben, Manager Human Resources | Edward Roos, Global Managing Director | Jo-Ann West MSc, Publisher, Rapid Publications and Reprint Services[6]
Contact
- Address:
- Excerpta Medica USA
- 685 US-202
- Bridgewater, NJ 08807
- Telephone +1 908 547 2100
- Fax +1 908 547 2200
- Excerpta Medica EuropeRadarweg 29
- 1043 NX Amsterdam
- Netherlands
- Telephone +31 20 485 3975
- Fax +31 20 485 3188 905 King Street West
- Excerpta Medica Interactive
- 4th Floor
- Toronto, ON
- M6K 3G9 Canada
- Telephone +1 416 955 9449
- Fax +1 416 955 9666
- Website:http://www.excerptamedica.com/
Resources
Notes
- ↑ Excerpta Medica Home page, accessed 16 August 2009
- ↑ Excerpta Medica Case Studies: With limited clinical support, how did Excerpta Medica establish a client’s product more prominently within its therapeutic marketplace?, accessed 26 August 2009
- ↑ Excerpta Medica Publication Policy, accessed 26 August 2009
- ↑ Bob Grant Elsevier published 6 fake journals 07 May 2009, The Scientist, accessed 26 August 2009
- ↑ Excerpta Medica Publication Policy, accessed 26 August 2009
- ↑ Excerpta Medica How to reach us, accessed 26 August 2009
